Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Liabilities and Shareholders Equity (2012 - 2026)

Zoetis' (ZTS) quarterly Liabilities and Shareholders Equity came in at $15.1 billion in Q2 2026, up 4.13% year-over-year from $14.5 billion in Q2 2025, and down 0.51% quarter-over-quarter from $15.2 billion in Q1 2026.

Analysis

Zoetis (ZTS) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Liabilities and Shareholders Equity for 15 consecutive years, with $15.1 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 4.13% year-over-year to $15.1 billion in Q2 2026; TTM through Jun 2026 was $60.9 billion, a 6.49% increase from a year earlier, with the FY2025 full-year figure at $15.5 billion, up 8.8% from the prior year.
  • Liabilities and Shareholders Equity was $15.1 billion for Q2 2026 at Zoetis, down from $15.2 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $15.5 billion in Q4 2025 and troughed at $13.7 billion in Q3 2022.
  • A 5-year average of $14.4 billion and a median of $14.3 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity fell 4.19% in 2023 and increased 8.8% in 2025, its largest moves.
  • Over 5 years, Liabilities and Shareholders Equity stood at $14.9 billion in 2022, then decreased by 4.19% to $14.3 billion in 2023, then fell by 0.44% to $14.2 billion in 2024, then rose by 8.8% to $15.5 billion in 2025, then declined by 2.67% to $15.1 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $15.1 billion (Q2 2026), $15.2 billion (Q1 2026), and $15.5 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn 3.44 Bn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 15.08 Bn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn 13.56 Bn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 1.50 Bn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn 46.63 Mn
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - 61.54 Mn
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - 539,261.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.08 Bn
Mar 31, 2026 15.15 Bn
Dec 31, 2025 15.49 Bn
Sep 30, 2025 15.16 Bn
Jun 30, 2025 14.48 Bn
Mar 31, 2025 14.10 Bn
Dec 31, 2024 14.24 Bn
Sep 30, 2024 14.36 Bn
Jun 30, 2024 14.17 Bn
Mar 31, 2024 14.35 Bn
Dec 31, 2023 14.30 Bn
Sep 30, 2023 14.11 Bn
Jun 30, 2023 13.75 Bn
Mar 31, 2023 13.75 Bn
Dec 31, 2022 14.93 Bn
Sep 30, 2022 13.67 Bn
Jun 30, 2022 13.77 Bn
Mar 31, 2022 13.86 Bn
Dec 31, 2021 13.90 Bn
Sep 30, 2021 13.71 Bn